Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 3 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Transarterial embolisation vs no intervention

Death during study period · people with liver metastases

It is very uncertain whether transarterial embolisation changes mortality at 44 months from trial entry Number of participants compared with no intervention (very low certainty).

1 finding from 1 review

Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases 2020 · Cochrane Headline outcomes only
RR 0.91 [0.75, 1.1]
1 study · 42 participants
Very low

Transarterial embolisation and transarterial chemoembolisation vs no intervention

Death during study period · people with liver metastases

It is very uncertain whether transarterial embolisation and transarterial chemoembolisation changes mortality at 44 months from trial entry Number of participants compared with no intervention (very low certainty).

1 finding from 1 review

Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases 2020 · Cochrane Headline outcomes only
RR 0.88 [0.74, 1.06]
1 study · 61 participants
Very low

Transarterial chemoembolisation vs no intervention

Death during study period · people with liver metastases

It is very uncertain whether transarterial chemoembolisation changes mortality at 44 months from trial entry Number of participants compared with no intervention (very low certainty).

1 finding from 1 review

Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases 2020 · Cochrane Headline outcomes only
RR 0.83 [0.65, 1.07]
1 study · 39 participants
Very low